Effects of Trypanocidal Treatment on Echocardiographic Parameters in Chagas Cardiomyopathy and Prognostic Value of Wall Motion Score Index: A BENEFIT Trial Echocardiographic Substudy

dc.creatorSchmidt, André
dc.creatorDias Romano, Minna Moreira
dc.creatorMarin-Neto, José Antônio
dc.creatorRao-Melacini, Purnima
dc.creatorRassi, Anis
dc.creatorMattos, Antônio
dc.creatorAvezum, Álvaro
dc.creatorVillena, Erick
dc.creatorSosa-Estani, Sergio
dc.creatorBonilla, Rina
dc.creatorYusuf, Salim
dc.creatorMorillo, Carlos A
dc.creatorMaciel, Benedito Carlos
dc.date2019-11-20T20:31:58Z
dc.date2019-11-20T20:31:58Z
dc.date2019-02
dc.date.accessioned2023-08-29T20:06:01Z
dc.date.available2023-08-29T20:06:01Z
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/1316
dc.identifier10.1016/j.echo.2018.09.006
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8518930
dc.descriptionSerial echocardiographic studies in chronic Chagas cardiomyopathy are scarce. The aims of this study were to evaluate whether therapy with benznidazole modifies the progression of cardiac impairment and to identify baseline echocardiographic parameters related to prognosis.
dc.languageen
dc.relationJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
dc.rightsnone
dc.subjectTerapia Tripanocida
dc.subjectEcocardiografía
dc.subjectPronóstico
dc.subjectCardiomiopatía Chagásica
dc.titleEffects of Trypanocidal Treatment on Echocardiographic Parameters in Chagas Cardiomyopathy and Prognostic Value of Wall Motion Score Index: A BENEFIT Trial Echocardiographic Substudy
dc.typeArtículo


Este ítem pertenece a la siguiente institución